AUROBINDO PHARMA
Back to Income Statement
|
AUROBINDO PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹31,724 Cr | ₹29,002 Cr | ₹24,855 Cr | ₹23,455 Cr | ₹24,775 Cr |
What is the latest Revenue of AUROBINDO PHARMA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹31,724 Cr |
| Mar2024 | ₹29,002 Cr |
| Mar2023 | ₹24,855 Cr |
| Mar2022 | ₹23,455 Cr |
| Mar2021 | ₹24,775 Cr |
How is Revenue of AUROBINDO PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹31,724 Cr | 9.39 | |
| Mar2024 | ₹29,002 Cr | 16.68 | |
| Mar2023 | ₹24,855 Cr | 5.97 | |
| Mar2022 | ₹23,455 Cr | -5.32 | |
| Mar2021 | ₹24,775 Cr | - | |
Compare Revenue of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹79,889.0 Cr | 0.8% | 4.2% | 22.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,083.0 Cr | -3.9% | -8.9% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,971.0 Cr | 3.8% | -4.7% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,660.0 Cr | 3.2% | -5.6% | 26.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,686.0 Cr | 3.3% | -6% | 11% | Stock Analytics | |
| CIPLA | ₹99,086.7 Cr | 0.8% | -9.1% | -13.1% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 0.8% |
4.2% |
22.2% |
| SENSEX | 4.7% |
-0.1% |
3.6% |
You may also like the below Video Courses